Application of a gene transfer strategy to identify molecules that incite autoimmune kidney injury

Experimental Nephrology

Volumn 5, Issue 2, 1997, Pages 144-151

  Kelley, Vicki Rubin ^a   Moore, Kathryn J ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

autoimmunity; cytokines; gene transfer; macrophage; retroviral vectors

Indexed keywords

CYTOKINE; VIRUS VECTOR;

ANIMAL CELL; AUTOIMMUNITY; GENE TRANSFER; KIDNEY DISEASE; KIDNEY INJURY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; REVIEW; THERAPY;

ANIMALS; CYTOKINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GROWTH SUBSTANCES; INTERLEUKIN-6; KIDNEY; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MICE, MUTANT STRAINS; MOLONEY MURINE LEUKEMIA VIRUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030888024     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bosch R, Woolf AS, Fine LG: Gene transfer into mammalian kidney: Direct retrovirus transduction of regenerating tubular epithelial cells. Exp Nephrol 1993;1:49-54.
2. Isaka Y, Fujiwara Y, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993;92:2597-2601.
3. Kitamura M, Tayler S, Fine LG: Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Invest 1994;94: 497-505.
4. Hayek A, Culler FL, Baird A: An in vivo model for study of the angiogenetic effects of basic fibroblast growth factor. Biochem Biophys Res Commun 1987;147:876-880.
5. Mendola JF, Goity C, Gomis R: Immunocytochemical study of pancreatic islet revascularization in islet isograft. Transplantation 1994; 57:725-730.
6. Kelley VE, Roths JB: Interaction of mutant lpr gene with background strain influences renal disease. Clin Immunol Immunopathol 1985; 37:220-229.
7. Watanabe-Fukunaga R, Brannan CI, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
8. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994;1:365-371.
9. Gallo CD, Jevnikar AM, Kelley VR: Autoreactive kidney-infiltrating T-cell clones in murine lupus nephritis. Kidney Int 1992;42:851-859.
10. Boswell JM, Yui MA, Kelley VE: Increased tumor necrosis factor and IL-1 β gene expression in the kidneys of mice with lupus nephritis. J Immunol 1988;141:3050-3054.
11. Yokoyama H, Kreft B, Kelley VR: Biphasic increase in circulating and renal TNF-α in MRL-lpr mice with differing regulatory mechanisms. Kidney Int 1995;47:122-130.
12. Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T: Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 1991;3:273-278.
13. Kelley VR, Bloom RD, Yui MA, Martin C, Price D: Pivotal role of colony stimulating factor-1 in lupus nephritis. Kidney Int 1994; 45(suppl):83.
14. Mulligan RC: Gene transfer and gene therapy. Principles, prospects, and perspective; in Lindsten J, Petterson U (eds): Etiology of Human Diseases at the DNA Level. New York, Raven Press, 1991, pp 143-189.
15. Danos O, Mulligan RC: Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci USA 1988;85:6460-6464.
16. Naito T, Moore KJ, Kelley VR: IL-6 neither promotes nor suppresses renal injury. Am J Physiol 1996, in press.
17. Moore KJ, Naito T, Martin C, Kelley VR: Enhanced response of macrophages to CSF-1 in autoimmune mice: A gene transfer strategy. J Immunol 1996, in press.
18. Moore KJ, Yeh K, Naito T, Kelley VR: TNF-α enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease. J Immunol 1996, in press.
19. Naito T, Yokoyama H, Moore KJ, Dranoff G, Mulligan RC, Kelley VR: Macrophage growth factors introduced into the kidney initiate renal injury. Mol Med 1996;2:297-312.
20. Morgan JR, LeDoux JM, Snow RG, Tompkins RG, Yarmush ML: Retrovirus infection: Effect of time and target cell number. J Virol 1995;69: 6994-7000.
21. Schreiner GF: The role of the macrophage in glomerular injury. Semin Nephrol 1991;11: 268-275.
22. Bloom RD, Florquin S, Kelley VR: Colony stimulating factor-1 in the induction of lupus nephritis. Kidney Int 1993;43:1000-1009.
23. Wang JM, Griffin JD, Mantovani A: Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 1988;141:575-579.
24. Metcalf D: The granulocyte-macrophage colony-stimulating factors. Science 1985;229:16-22.
25. Yui MA, Brissette WH, Brennan DC, Wuthrich RP, Kelley VE: Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice. Am J Pathol 1991;139:255-261.
26. Brennan DC, Jevnikar AJ, Bloom RD, Brissctte WH, Singer GG, Rubin-Kelley VE: Cultured mesangial cells from autoimmune MRL-lpr mice have decreased secreted and surface M-CSF. Kidney Int 1992;42:279.
27. Naito T, Griffiths RC, Coffman TM, Kelley VR: Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice. Kidney Int 1996;49:67-74.
28. Brennan DC, Yui MA, Wuthrich RP, Kelley VR: Tumor necrosis factor and IL-1 in New Zealand black/white mice. Enhanced gene expression and accelerated renal injury. J Immunol 1989;143:3470-3475.
29. Bemelmans MHA, Gouma DJ, Buurman WA: LPS-induced sTNF-receptor release in vivo in a murine model. J Immunol 1993;151:554.